PGMBM has welcomed the publication of an independent report into the safety and side-effects of treatments recommended and administered by the British healthcare industry, including Primodos. After a two-year study, the Independent Medicines and Medical Devices Safety (IMMDS) review was published by Baroness Cumberlege and entitled First Do No Harm. The report details the grim history of Primodos, a hormone pregnancy test drug, Sodium Valproate, an anti-epilepsy drug, and vaginal mesh used to support weakened pelvic organs and repair damaged tissue. It sets forth the various ways the regulators and

PGMBM has announced today that it is taking legal action against vehicle manufacturers Nissan and Renault, following allegations that illegal emissions defeat devices have been fitted in a number of cars and vans. Defeat devices are designed to sense when a car is under specific testing conditions, and accordingly turn on emissions controls, allowing the vehicle to falsely pass regulatory checks. PGMBM claim that, as a result of defeat devices, customers who owned or leased a Renault or Nissan car or van between 2009 and 2019 may have been deliberately

PGMBM has instructed Sophie Holcombe and David Blayney QC of Serle Court in ongoing litigation against the aviation giant easyJet. In May, the airline announced that it had been subjected to a data theft attack, under which the confidential information of over nine million customers had been breached.  In over 2,000 cases, this included credit card details, alongside email addresses, names and travel itineraries. One of the UK’s largest data breaches to date, questions have been raised as to the efficacy of the cyber-security measures in place at easyJet, and